[Form 4] Co-Diagnostics, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Co-Diagnostics, Inc. (CODX) insider report: Dwight H. Egan, listed as Director and Chief Executive Officer, was granted 275,000 restricted stock units (RSUs) on 08/13/2025 under the Issuer's 2015 Long Term Incentive Plan, as amended. Each RSU represents the contingent right to receive one share of common stock upon vesting. Following the grant, Mr. Egan beneficially owns 575,833 shares of common stock. The RSUs vest in six equal installments beginning 11/23/2025 and continue every six months thereafter.

Positive

• 275,000 RSUs granted to Dwight H. Egan on 08/13/2025
• Beneficial ownership reported as 575,833 shares following the grant
• Vesting schedule disclosed: six installments commencing 11/23/2025 and every six months thereafter

Negative

• None.

Insights

Financial Analyst

TL;DR: CEO received a sizeable RSU grant increasing reported beneficial ownership to 575,833 shares.

The filing documents a grant of 275,000 restricted stock units to Dwight H. Egan on 08/13/2025 under the company's 2015 Long Term Incentive Plan. The RSUs are contingent rights to one share each and vest in six installments starting 11/23/2025 and every six months thereafter. After the grant, beneficial ownership is reported as 575,833 shares. This is a straightforward disclosure of executive compensation and ownership; no exercise prices or derivative conversions are reported.

Corporate Governance Expert

TL;DR: Disclosure shows standard equity-based compensation with a multi-period vesting schedule for the CEO/director.

The Form 4 identifies Dwight H. Egan as both a director and the Chief Executive Officer and records an award of 275,000 RSUs granted pursuant to the 2015 Long Term Incentive Plan. The RSU instrument is described as a contingent right to receive common stock upon vesting. The filing includes the vesting cadence—six installments beginning 11/23/2025 and continuing every six months—and reports total beneficial ownership of 575,833 shares. The document is a routine Section 16 filing providing required transparency on insider ownership and compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Egan Dwight H

(Last) (First) (Middle)

2401 S. FOOTHILL DRIVE SUITE D

(Street)

SALT LAKE CITY UT 84109

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Co-Diagnostics, Inc. [ CODX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/13/2025		A		275,000		(2)	(2)	Common Stock	300,833	$0.00	575,833	D

Explanation of Responses:

1. Granted pursuant to Issuer's 2015 Long Term Incentive Plan, as amended. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's common stock.

2. RSU vests in 6 installments commencing on 11/23/25 and continues every 6 months thereafter.

Remarks:

	/s/ Dwight H. Egan	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Dwight H. Egan report on the Form 4 for CODX?

The Form 4 reports a grant of 275,000 restricted stock units (RSUs) to Dwight H. Egan on 08/13/2025 and discloses total beneficial ownership of 575,833 shares.

What is the nature of the securities granted to the reporting person?

The award consists of restricted stock units (RSUs), where each RSU is the contingent right to receive one share of the issuer's common stock upon vesting.

When do the RSUs granted to the CEO vest?

The RSUs vest in six installments beginning on 11/23/2025 and continue every six months thereafter.

Under which plan were the RSUs granted?

The RSUs were granted pursuant to the issuer's 2015 Long Term Incentive Plan, as amended.

What positions does Dwight H. Egan hold at Co-Diagnostics, Inc. as stated on the Form 4?

He is reported as a Director and as an Officer with the title Chief Executive Officer.